Savara (NASDAQ:SVRA) Stock Price Up 2.5% - Here's Why

Savara (NASDAQ:SVRA) Stock Price Up 2.5% - Here's Why

Savara (NASDAQ:SVRA) Trading Up 2.5% - Here's What Happened

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 91.71% Potential Upside

Savara, Inc. (SVRA) has recently captured the attention of investors with its promising growth potential in the biotech sector, specifically in the niche market of rare respiratory diseases. With a market capitalization of $1.15 billion, this Langhorne, Pennsylvania-based company is making waves with its lead product candidate, molgramostim. Currently in the Phase 3 development stage, molgramostim is designed to treat autoimmune pulmonary alveol…